Published 13 days ago • loading... • Updated 13 days ago

AbbVie, Pfizer gain FDA OK for novel antibiotic

Summary by biopharmadive.com

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.

6 Articles

All

Left

Center

Right

biopharmadive.com

AbbVie, Pfizer gain FDA OK for novel antibiotic

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.

13 days ago

Read Full Article

pharmtech.com

FDA Approves AbbVie Treatment for Complicated Intra-Abdominal Infections

These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.

13 days ago

Read Full Article

healtheconomics.com

FDA Approves AbbVie and Pfizer's Novel Antibiotic Emblaveo for Complex Infections

The U.S. Food and Drug Administration has granted approval for Emblaveo, a novel combination antibiotic developed by AbbVie and Pfizer, designed to tackle complicated intra-abdominal infections. Emblaveo is intended for use in conjunction with metronidazole for adults facing limited or no other treatment options, specifically targeting infections caused by challenging gram-negative bacteria such as E. coli and Klebsiella pneumoniae. These bacter…

13 days ago

Read Full Article

Managed Healthcare Executive

FDA Approves Combination Antibiotic for Complicated Infections

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

13 days ago

Read Full Article

Cantech Letter

What drugs for animals does Pfizer manufacture?

Pfizer’s history dates back to 1849 when German immigrants Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in Brooklyn, New York. Their first product was an antiparasitic drug called santonin, which was used to treat intestinal worms. The company quickly expanded its pharmaceutical offerings, gaining recognition for its ability to produce high-quality chemical […] Source

13 days ago

Read Full Article